Main navigation
You are here
- Home
- Investors
- Financial results
2000 Financial results
8 February 2001
25 October 2000
1 August 2000
3 May 2000
Fourth quarter and full year results 2000
25 October 2000
Third quarter and nine months results 2000
1 August 2000
Second quarter and half year results 2000
R&D pipeline table - (PDF 36 kb)
3 May 2000
First quarter results 2000
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 09:00 GMT
Detailed share priceStock symbol - AZN
On LSE, NYSE and OMX
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
